Related Experiment Video
Updated: Aug 14, 2026
11:09
Constructing Thioether/Vinyl Sulfide-tethered Helical Peptides Via Photo-induced Thiol-ene/yne Hydrothiolation
Published on: August 1, 2018
Novel endotoxin-sequestering compounds with terephthalaldehyde-bis-guanylhydrazone scaffolds
Kriangsak Khownium1, Stewart J Wood, Kelly A Miller
1Department of Medicinal Chemistry, University of Kansas, 1251 Wescoe Hall Drive, Lawrence KS 66045-7582, USA.
Bioorganic & Medicinal Chemistry Letters
|December 27, 2005
Summary
Researchers developed novel bis-guanylhydrazone compounds that neutralize harmful lipopolysaccharide (LPS) from Gram-negative bacteria. These compounds show potential as alternatives to polymyxin B for treating endotoxic shock.
Area of Science:
- Medicinal Chemistry
- Microbiology
- Pharmacology
Background:
- Lipopolysaccharide (LPS), a component of Gram-negative bacterial outer membranes, causes endotoxic shock.
- Lipopolyamines neutralize LPS toxicity by binding to its lipid A component.
- There is a need for non-polyamine scaffolds with similar endotoxin-neutralizing properties.
Purpose of the Study:
- To identify novel non-polyamine compounds that can bind and neutralize LPS.
- To explore guanylhydrazone scaffolds as potential LPS-binding agents.
- To synthesize and evaluate bis-guanylhydrazone derivatives for endotoxin neutralization.
Main Methods:
- High-throughput screening identified guanylhydrazone scaffolds.
- Synthesis of a homologous series of bis-guanylhydrazone compounds with hydrophobic functionalities.
- Evaluation of compound potency in binding and neutralizing LPS in vitro and in animal models.
Main Results:
- Bis-guanylhydrazone compounds were synthesized and characterized.
- These compounds demonstrated the ability to bind to LPS.
- The synthesized compounds neutralized LPS toxicity with potency comparable to polymyxin B.
Conclusions:
- Bis-guanylhydrazone derivatives represent a promising new class of compounds for neutralizing LPS.
- These findings suggest potential therapeutic applications in managing Gram-negative bacterial infections and endotoxemia.
- Further structure-activity relationship studies are warranted to optimize these novel endotoxin neutralizers.
